Search Results - "Kraft, Maria Beatriz de Paula Leite"

Postplacental Placement of Intrauterine Devices: Acceptability, Reasons for Refusal and Proposals to Increase its Use by Kraft, Maria Beatriz de Paula Leite, Miadaira, Mariana, Marangoni, Júnior, Marcos, Juliato, Cássia Raquel Teatin, Surita, Fernanda Garanhani

“…To evaluate the acceptability of postplacental placement of intrauterine devices (PPIUD), reasons for refusal and suggested policies to increase its use. …”
Get full text

ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy by Reinert, Tomás, Ramalho, Susana, de Vasconcelos, Vivian Castro Antunes, Silva, Leonardo Roberto, da Silva, Ana Elisa Ribeiro, de Andrade, Camila Annicchino, Kraft, Maria Beatriz de Paula Leite, Coelho, Guilherme Portela, Mandelli, Jovana, Binotto, Monique, Cabello, Cesar, de Paiva Silva, Geisilene Russano, Bines, José, Barrios, Carlos H, Ellis, Matthew J, Graudenz, Marcia Silveira

“…Mutations in the gene ( m) are important mechanisms of resistance to endocrine therapy in estrogen receptor-positive (ER+) metastatic breast cancer and have…”
Get full text

Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer by da Silva, Leonardo Roberto, de Andrade, Camila Annicchino, Brenelli, Fabrício, Ramalho, Susana, Reinert, Tomás, de Souza, Alessandra Borba Anton, da Silva, Ana Elisa Ribeiro, de Paula Leite Kraft, Maria Beatriz, de Vasconcelos, Vivian Castro Antunes, Frasson, Antônio Luiz, Torresan, Renato Zochio, Cabello, Cesar, Ellis, Matthew J., Zeferino, Luiz Carlos

“…Purpose Neoadjuvant endocrine therapy (NET) has been shown to be effective in ER-positive/HER2-negative breast cancer in clinical trials. However, adoption in…”
Get full text